OptimizeRx Corp
OPRX· Nasdaq
OPRXOptimizeRx Corp
Filed May 15, 2012 · 10-Q · 45 days after period end · 0001255294-12-000308
| Metric | Q1 2012 | Q1 2011 |
|---|---|---|
| Revenue | $329.40K | $393.84K |
| Net Income | -$300.73K | -$379.93K |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
OptimizeRx Corp · CIK 1448431 · Engraved from SEC EDGAR
ended Mar 31, 2012 · filed May 15, 2012 · 45 d after period end
